Subject: FDA Approval Is Received To Test Carrisyn on Humans
Date: Published: 11/29/88 26 lines
Source:  Wall Street Journal.  Copyright Dow Jones & Co. Inc. 

    Technology Brief -- Carrington Laboratories Inc.:  
    FDA Approval Is Received
    To Test Drug on Humans

    Carrington Laboratories Inc. said it received Food and
 Drug Administration approval to begin testing the toxicity of
 its Carrisyn drug on humans.
    Carrington said it will give several different dosage
 levels of Carrisyn to 24 healthy patients in an eight-week
 test and expects a final report in four months.
    The Dallas pharmaceutical concern has said it believes
 Carrisyn, which is developed from an aloe vera plant extract,
 could be effective in treating acquired immune deficiency
 syndrome and other viral diseases by stimulating the immune
 system.
    As previously reported, the company currently is testing
 the drug on patients with AIDS in Belgium.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]